Dig Dis Sci:炎症性肠病疾病活动和表型对孕前和孕妇生活质量的影响

2022-08-19 xuyihan MedSci原创

炎症性肠病,是病灶累及回肠、直肠、结肠的一种特发性肠道的炎症性疾病。临床常见表现为腹泻、腹痛。

炎症性肠病 (IBD)主要包括克罗恩病 (CD) 和溃疡性结肠炎 (UC),是一种与令人非常痛苦的慢性复发性炎症性疾病。IBD最常在青春期和青年期被诊断出来,它会影响患者的自尊、心理健康和身体形象。而患有IBD的育龄妇女在应对妊娠和 IBD 之间的相互作用方面面临着额外的挑战。患有 IBD 的女性更可能没有孩子,在CD和UC患者中的发生率分别为18%和14%,而在普通人群中为6.2%,这种现象被认为是适龄期妇女对妊娠期IBD治疗的误解和恐惧。

健康相关的生活质量 (HRQoL) 量表是一种经过验证的评估IBD患者生活质量的工具。IBD 相关的 HRQoL 受到疾病活动的极大影响,因此,评估 IBD 孕妇 HRQoL 的预测因素对于制定优化孕期HRQoL和IBD管理的策略至关重要,目前尚不清楚IBD相关 HRQoL如何在孕前(PC)、妊娠和产后的不同时间点受到影响。因此,本项研究旨在前瞻性评估 IBD 女性从 PC 到产后的纵向变化。

研究人员在一家三级转诊中心对孕前到产后12个月内的IBD孕妇患者进行了前瞻性研究。参与者完成了简短的IBD问卷 (SIBDQ),并评估了临床疾病活动性(改良的 Harvey Bradshaw 指数或Mayo评分)和客观疾病活动性(C反应蛋白 [CRP]、粪便钙卫蛋白 [FCP])。

本项研究最后共纳入61名IBD患者(25名CD,36名UC)。研究结果显示在孕前,UC 患者的 SIBDQ 肠道和社交评分高于CD患者,但在产后发生逆转。患有CD而不是UC的患者在怀孕后SIBDQ出现显着的改善,这种改善持续到产后12个月。在多变量线性回归模型中,临床疾病活动对每个妊娠时间点和产后 12 个月的 SIBDQ都有负性预测作用。同时研究人员发现CRP≥8.0mg/L 的患者在妊娠1个月 (T1) 期间的SIBDQ显着降低,但在妊娠后期不显着。FCP≥250mg/kg的患者在 T2、T3 和产后6个月时的SIBDQ评分显着降低。

本项研究证实临床疾病活动是从IBD孕妇受孕到产后12个月生活质量的负预测因子。UC 患者的孕前 HRQoL 更好,但产后 HRQoL比CD患者更差。

原始出处:

Grace Wang. et al. Impact of Disease Activity and Inflammatory Bowel Disease Subtype on Quality of Life in Preconception and Pregnant Patients. Digestive Diseases and Sciences.2022.

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2013942, encodeId=70dd2013942ea, content=<a href='/topic/show?id=7d69598468' target=_blank style='color:#2F92EE;'>#Dis#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5984, encryptionId=7d69598468, topicName=Dis)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c689267, createdName=cmj8wellington, createdTime=Wed Feb 01 10:13:21 CST 2023, time=2023-02-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1756127, encodeId=0a781e56127d4, content=<a href='/topic/show?id=78e1e06924a' target=_blank style='color:#2F92EE;'>#疾病活动#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70692, encryptionId=78e1e06924a, topicName=疾病活动)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=57fa37069463, createdName=xue8614, createdTime=Tue Jul 18 14:13:21 CST 2023, time=2023-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1659617, encodeId=d8f8165961ed2, content=<a href='/topic/show?id=c42845239ef' target=_blank style='color:#2F92EE;'>#孕前#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45239, encryptionId=c42845239ef, topicName=孕前)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2c8925003801, createdName=szhvet, createdTime=Fri Dec 09 18:13:21 CST 2022, time=2022-12-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1535344, encodeId=22b41535344d2, content=<a href='/topic/show?id=099f9020145' target=_blank style='color:#2F92EE;'>#表型#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90201, encryptionId=099f9020145, topicName=表型)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9b6412593156, createdName=tastas, createdTime=Sat Aug 20 14:13:21 CST 2022, time=2022-08-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1547584, encodeId=3325154e58498, content=<a href='/topic/show?id=4ef26e01766' target=_blank style='color:#2F92EE;'>#炎症性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=67017, encryptionId=4ef26e01766, topicName=炎症性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=09e813968720, createdName=12498dd9m15暂无昵称, createdTime=Sat Aug 20 14:13:21 CST 2022, time=2022-08-20, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=2013942, encodeId=70dd2013942ea, content=<a href='/topic/show?id=7d69598468' target=_blank style='color:#2F92EE;'>#Dis#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5984, encryptionId=7d69598468, topicName=Dis)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c689267, createdName=cmj8wellington, createdTime=Wed Feb 01 10:13:21 CST 2023, time=2023-02-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1756127, encodeId=0a781e56127d4, content=<a href='/topic/show?id=78e1e06924a' target=_blank style='color:#2F92EE;'>#疾病活动#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70692, encryptionId=78e1e06924a, topicName=疾病活动)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=57fa37069463, createdName=xue8614, createdTime=Tue Jul 18 14:13:21 CST 2023, time=2023-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1659617, encodeId=d8f8165961ed2, content=<a href='/topic/show?id=c42845239ef' target=_blank style='color:#2F92EE;'>#孕前#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45239, encryptionId=c42845239ef, topicName=孕前)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2c8925003801, createdName=szhvet, createdTime=Fri Dec 09 18:13:21 CST 2022, time=2022-12-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1535344, encodeId=22b41535344d2, content=<a href='/topic/show?id=099f9020145' target=_blank style='color:#2F92EE;'>#表型#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90201, encryptionId=099f9020145, topicName=表型)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9b6412593156, createdName=tastas, createdTime=Sat Aug 20 14:13:21 CST 2022, time=2022-08-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1547584, encodeId=3325154e58498, content=<a href='/topic/show?id=4ef26e01766' target=_blank style='color:#2F92EE;'>#炎症性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=67017, encryptionId=4ef26e01766, topicName=炎症性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=09e813968720, createdName=12498dd9m15暂无昵称, createdTime=Sat Aug 20 14:13:21 CST 2022, time=2022-08-20, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=2013942, encodeId=70dd2013942ea, content=<a href='/topic/show?id=7d69598468' target=_blank style='color:#2F92EE;'>#Dis#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5984, encryptionId=7d69598468, topicName=Dis)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c689267, createdName=cmj8wellington, createdTime=Wed Feb 01 10:13:21 CST 2023, time=2023-02-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1756127, encodeId=0a781e56127d4, content=<a href='/topic/show?id=78e1e06924a' target=_blank style='color:#2F92EE;'>#疾病活动#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70692, encryptionId=78e1e06924a, topicName=疾病活动)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=57fa37069463, createdName=xue8614, createdTime=Tue Jul 18 14:13:21 CST 2023, time=2023-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1659617, encodeId=d8f8165961ed2, content=<a href='/topic/show?id=c42845239ef' target=_blank style='color:#2F92EE;'>#孕前#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45239, encryptionId=c42845239ef, topicName=孕前)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2c8925003801, createdName=szhvet, createdTime=Fri Dec 09 18:13:21 CST 2022, time=2022-12-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1535344, encodeId=22b41535344d2, content=<a href='/topic/show?id=099f9020145' target=_blank style='color:#2F92EE;'>#表型#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90201, encryptionId=099f9020145, topicName=表型)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9b6412593156, createdName=tastas, createdTime=Sat Aug 20 14:13:21 CST 2022, time=2022-08-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1547584, encodeId=3325154e58498, content=<a href='/topic/show?id=4ef26e01766' target=_blank style='color:#2F92EE;'>#炎症性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=67017, encryptionId=4ef26e01766, topicName=炎症性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=09e813968720, createdName=12498dd9m15暂无昵称, createdTime=Sat Aug 20 14:13:21 CST 2022, time=2022-08-20, status=1, ipAttribution=)]
    2022-12-09 szhvet
  4. [GetPortalCommentsPageByObjectIdResponse(id=2013942, encodeId=70dd2013942ea, content=<a href='/topic/show?id=7d69598468' target=_blank style='color:#2F92EE;'>#Dis#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5984, encryptionId=7d69598468, topicName=Dis)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c689267, createdName=cmj8wellington, createdTime=Wed Feb 01 10:13:21 CST 2023, time=2023-02-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1756127, encodeId=0a781e56127d4, content=<a href='/topic/show?id=78e1e06924a' target=_blank style='color:#2F92EE;'>#疾病活动#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70692, encryptionId=78e1e06924a, topicName=疾病活动)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=57fa37069463, createdName=xue8614, createdTime=Tue Jul 18 14:13:21 CST 2023, time=2023-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1659617, encodeId=d8f8165961ed2, content=<a href='/topic/show?id=c42845239ef' target=_blank style='color:#2F92EE;'>#孕前#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45239, encryptionId=c42845239ef, topicName=孕前)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2c8925003801, createdName=szhvet, createdTime=Fri Dec 09 18:13:21 CST 2022, time=2022-12-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1535344, encodeId=22b41535344d2, content=<a href='/topic/show?id=099f9020145' target=_blank style='color:#2F92EE;'>#表型#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90201, encryptionId=099f9020145, topicName=表型)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9b6412593156, createdName=tastas, createdTime=Sat Aug 20 14:13:21 CST 2022, time=2022-08-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1547584, encodeId=3325154e58498, content=<a href='/topic/show?id=4ef26e01766' target=_blank style='color:#2F92EE;'>#炎症性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=67017, encryptionId=4ef26e01766, topicName=炎症性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=09e813968720, createdName=12498dd9m15暂无昵称, createdTime=Sat Aug 20 14:13:21 CST 2022, time=2022-08-20, status=1, ipAttribution=)]
    2022-08-20 tastas
  5. [GetPortalCommentsPageByObjectIdResponse(id=2013942, encodeId=70dd2013942ea, content=<a href='/topic/show?id=7d69598468' target=_blank style='color:#2F92EE;'>#Dis#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5984, encryptionId=7d69598468, topicName=Dis)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c689267, createdName=cmj8wellington, createdTime=Wed Feb 01 10:13:21 CST 2023, time=2023-02-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1756127, encodeId=0a781e56127d4, content=<a href='/topic/show?id=78e1e06924a' target=_blank style='color:#2F92EE;'>#疾病活动#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70692, encryptionId=78e1e06924a, topicName=疾病活动)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=57fa37069463, createdName=xue8614, createdTime=Tue Jul 18 14:13:21 CST 2023, time=2023-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1659617, encodeId=d8f8165961ed2, content=<a href='/topic/show?id=c42845239ef' target=_blank style='color:#2F92EE;'>#孕前#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45239, encryptionId=c42845239ef, topicName=孕前)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2c8925003801, createdName=szhvet, createdTime=Fri Dec 09 18:13:21 CST 2022, time=2022-12-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1535344, encodeId=22b41535344d2, content=<a href='/topic/show?id=099f9020145' target=_blank style='color:#2F92EE;'>#表型#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90201, encryptionId=099f9020145, topicName=表型)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9b6412593156, createdName=tastas, createdTime=Sat Aug 20 14:13:21 CST 2022, time=2022-08-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1547584, encodeId=3325154e58498, content=<a href='/topic/show?id=4ef26e01766' target=_blank style='color:#2F92EE;'>#炎症性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=67017, encryptionId=4ef26e01766, topicName=炎症性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=09e813968720, createdName=12498dd9m15暂无昵称, createdTime=Sat Aug 20 14:13:21 CST 2022, time=2022-08-20, status=1, ipAttribution=)]

相关资讯

AP&T: 炎症性肠病患者患痴呆风险明显增加

痴呆是指慢性获得性进行性智能障碍综合征。临床上以缓慢出现的智能减退为主要特征,伴有不同程度的人格改变。

JGH:硫唑嘌呤治疗不会导致炎症性肠病患者淋巴瘤和非黑色素瘤皮肤癌的风险增加

硫唑嘌呤是巯嘌呤的咪唑衍生物,在体内分解为巯嘌呤而起作用。它的免疫作用机制与巯嘌呤相同,也就是具有嘌呤拮抗作用。

J Autoimmunity:ETS-1通过上调CIRBP促进炎症性肠病中Th1细胞介导的黏膜炎症

该研究数据表明ETS-1在炎症性肠病(IBD)患者中高度表达,并通过冷诱导RNA结合蛋白(CIRBP)促进Th1驱动的粘膜炎症。CIRBP可作为治疗人类IBD的新治疗靶点。

IBD:炎症性肠病抗TNF治疗前后严重感染的风险:一项回顾性队列研究

黏膜的愈合可能超过了对感染风险的不良免疫抑制作用,并强调了治疗基础疾病的重要性。这些发现适用于与病人一起评估疗法的风险和益处。

AP&T: 炎症性肠病的疾病严重程度指数与心理症状和生活质量相关

克罗恩病影响人的正常生活。因为克罗恩病会导致长时间腹泻的症状,所以会影响正常的生活质量。

炎症性肠病(IBD)的分子机制和免疫治疗

在未来,特定基因位点的改变可能是IBD很有希望的治疗方法。新型抗体或抑制剂、联合治疗方案和多因子阻断剂也有望打破IBD治疗的瓶颈,为IBD的患者的疾病改善带来福音。